No Data
No Data
Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction With 2025 AACR Annual Meeting
Why PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Popularity With Investors Under Threat As Stock Sinks 27%
Foghorn Therapeutics Will Present New Preclinical Data For Selective SMARCA2 Inhibitor FHD-909 And Selective CBP And EP300 Degrader Programs At 2025 AACR Meeting In Chicago April 24-20, 2025
Lilly Announces Details of Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica, an AI-Powered Drug Discovery Platform